Positions

Principal Investigator On

  • ADVANCING ALSTATE (Alabama Lifespan Sickle cell Tracking Access Towards Equality) Network  awarded by CDC - Centers for Disease Control and Prevention/DHHS 2020 - 2023
  • Private Grant  awarded by BLUEBIRD BIO INC. 2020 - 2023
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2020 - 2023
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2019 - 2023
  • Private Grant  awarded by IMARA INC. 2020 - 2022
  • Private Grant  awarded by GLOBAL BLOOD THERAPEUTICS, INC. 2020 - 2022
  • DISPLACE: Dissemination and Implementation of Stroke Prevention Looking at the Care Environment  awarded by National Heart, Lung, and Blood Institute/NIH/DHHS 2019 - 2022
  • Private Grant  awarded by BAXALTA US INC. 2019 - 2021
  • Sickle Cell Treatment Demonstration Program - EMBRACE  awarded by CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY - DBA ATRIUM HEALTH 2019 - 2021
  • Private Grant  awarded by BLUEBIRD BIO INC. 2019 - 2021
  • Implementation of a Sickle Cell Enhanced Novel Care Network in South Carolina (iSCENSC)  awarded by Medical University of South Carolina 2019 - 2021
  • 1/2 Sickle Cell Disease and CardioVascular Risk-Red Cell Exchange Trial (SCDCARRE Trial)  awarded by University of Pittsburgh The 2019 - 2021
  • Sickle Cell Disease and Cardiovascular Risk-Red Cell Exchange Trial (SCD-CARRE)  awarded by University of Pittsburgh The 2019 - 2021
  • Private Grant  awarded by TAUTONA RESEARCH AND DEVELOPMENT COMPANY LLC 2020 - 2021
  • Private Grant  awarded by CYCLERION THERAPEUTICS INC 2019 - 2020
  • ALSTATE (Alabama Lifespan Sickle Cell Tracking Access Towards Equality) Network  awarded by CDC - Centers for Disease Control and Prevention/DHHS 2019 - 2020
  • Private Grant  awarded by IMARA INC. 2019 - 2020
  • Education And Training

  • Doctor of Medicine, Tulane University 2004
  • Bachelor of Arts in Biology, Washington University/St. Louis 1999
  • Full Name

  • Julie Kanter